ReviewGland surgery2026
Beyond levothyroxine: a narrative review of adjunctive management strategies for Hashimoto's thyroiditis.
Review in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Hashimoto's thyroiditis (HT) is the most common autoimmune thyroid disorder and the leading cause of hypothyroidism worldwide. Standard management primarily relies on thyroid hormone replacement, with surgical intervention reserved for patients with compressive symptoms or malignancy. Although biochemical euthyroidism can usually be achieved with appropriate hormone therapy, a subset of patients continues to report persistent symptoms such as fatigue, cognitive difficulty, weight changes, and reduced quality of life (QOL), even after biochemical optimization. This narrative review summarizes current evidence on adjunctive, non-hormonal, and non-surgical management strategies for HT. Methods: A narrative review of the literature was conducted to evaluate available data on alternative medicine approaches, dietary interventions, lifestyle modification, and nutritional supplementation, with particular attention to clinical outcomes, autoimmune markers, and patient-reported symptom improvement. Key Content and Findings: Emerging adjunct strategies include wet cupping, acupuncture, dietary modification, physical activity, and micronutrient supplementation. Some studies have reported improvements in QOL, autoimmune activity, or symptom burden; however, the existing evidence is heterogeneous, methodologically limited, and often based on small or uncontrolled studies. Conclusions: Adjunctive therapies may offer potential benefit for selected patients with persistent symptoms beyond conventional hormone replacement, but current data are insufficient to support definitive clinical recommendations. High-quality randomized controlled trials are needed to clarify efficacy, safety, and the role of these interventions in individualized patient care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.